Atlas Trials

Long-term Safety Study of Arsenic Trioxide in Newly Diagnosed, Low-to-intermediate Risk Acute Promyelocytic Leukemia

Clinical trial NCT03751917 · UNKNOWN

Trial details

NCT number
NCT03751917
Sponsor
Gruppo Italiano Malattie EMatologiche dell'Adulto
Status
UNKNOWN
Study type
OBSERVATIONAL
Acute Promyelocytic Leukemia
Start date
2020-04-14
Primary completion
2024-12-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.